Literature DB >> 20136710

Quantitation of bleeding symptoms in children with von Willebrand disease: use of a standardized pediatric bleeding questionnaire.

T T Biss1, V S Blanchette, D S Clark, M Bowman, C D Wakefield, M Silva, D Lillicrap, P D James, M L Rand.   

Abstract

SUMMARY
BACKGROUND: Excessive bruising and mucocutaneous bleeding are frequent presenting symptoms in childhood. A detailed bleeding history can distinguish children who may have an inherited bleeding disorder from those who are normal. There is a lack of standardization of such history taking in pediatric practise.
OBJECTIVES: To assess the performance of a Pediatric Bleeding Questionnaire (PBQ), an adaptation of a standardized adult bleeding questionnaire and score that includes pediatric-specific bleeding symptoms, in a cohort of children with von Willebrand disease (VWD). PATIENTS/
METHODS: Bleeding scores were determined by interview, for children with a previous diagnosis of VWD and a control group of unaffected siblings.
RESULTS: Bleeding scores were obtained for 100 children with VWD, median age 10.9 years (range, 0.8-17.8 years), and 21 unaffected siblings. Median bleeding score in children with VWD was 7.0 (range, 0-29) and in the control group was 0 (range, -1-2). Bleeding score varied within and between each VWD type: definite type 1, n = 40, median, 9.0 (range, 2-18); possible type 1, n = 38, median, 2.0 (0-15); type 2, n = 6, median, 14.0 (3-17); and type 3, n = 16, median, 12.0 (4-29). Bleeding scores in affected children correlated with age (Spearman's correlation coefficient, 0.35; P = 0.0004). The most frequent clinically significant bleeding symptoms were surgical bleeding, bleeding after tooth extraction and menorrhagia. Post-circumcision bleeding, cephalohematoma, macroscopic hematuria and umbilical stump bleeding were clinically significant in 32% (of circumcised males), 4%, 4% and 3% of children, respectively.
CONCLUSIONS: The PBQ provides a standardized quantitation of bleeding severity in children with VWD.

Entities:  

Mesh:

Year:  2010        PMID: 20136710     DOI: 10.1111/j.1538-7836.2010.03796.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

Review 1.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Blood       Date:  2017-11-30       Impact factor: 22.113

2.  Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease.

Authors:  M Deforest; J Grabell; S Albert; J Young; A Tuttle; W M Hopman; P D James
Journal:  Haemophilia       Date:  2015-07-14       Impact factor: 4.287

Review 3.  Laboratory aspects of von Willebrand disease: test repertoire and options for activity assays and genetic analysis.

Authors:  G Castaman; A Hillarp; A Goodeve
Journal:  Haemophilia       Date:  2014-05       Impact factor: 4.287

Review 4.  Abnormal Uterine Bleeding in Young Women with Blood Disorders.

Authors:  Kathryn E Dickerson; Neethu M Menon; Ayesha Zia
Journal:  Pediatr Clin North Am       Date:  2018-06       Impact factor: 3.278

Review 5.  The evolution and value of bleeding assessment tools.

Authors:  Natalia Rydz; Paula D James
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

Review 6.  von Willebrand disease: clinical and laboratory lessons learned from the large von Willebrand disease studies.

Authors:  Paula D James; David Lillicrap
Journal:  Am J Hematol       Date:  2012-03-03       Impact factor: 10.047

Review 7.  Advances in the diagnosis and treatment of Von Willebrand disease.

Authors:  Ruchika Sharma; Veronica H Flood
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

8.  Strategies in Clinical and Laboratory Diagnosis of Inherited Platelet Function Disorders in Children.

Authors:  Ralf Knöfler; Werner Streif
Journal:  Transfus Med Hemother       Date:  2010-09-15       Impact factor: 3.747

9.  Third Åland islands conference on von Willebrand disease, 26-28 September 2012: meeting report.

Authors:  E Berntorp; B Fuchs; M Makris; R Montgomery; V Flood; J S O'Donnell; A B Federici; D Lillicrap; P James; U Budde; M Morfini; P Petrini; S Austin; C Kannicht; V Jiménez-Yuste; C Lee
Journal:  Haemophilia       Date:  2013-03       Impact factor: 4.287

Review 10.  New developments in von Willebrand disease.

Authors:  Helen Fogarty; Dearbhla Doherty; James S O'Donnell
Journal:  Br J Haematol       Date:  2020-05-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.